Introduction
Anti-aging research is one of the most active areas of peptide science. From telomere biology to mitochondrial function to growth hormone axis optimization, peptides are being studied across multiple biological pathways implicated in the aging process. This overview summarizes the current state of peptide evidence in anti-aging research.
The Biological Hallmarks of Aging
Anti-aging peptide research is most coherent when organized around the established hallmarks of aging: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. Effective anti-aging research compounds are those with evidence of addressing one or more of these biological processes rather than merely claiming broad longevity benefits.
Telomere-Targeting Peptides
Epithalon is the primary research peptide studied for telomere biology. Research from Khavinson’s group has documented telomerase activation and telomere elongation in human somatic cell models and animal longevity studies. Telomere shortening is a well-established hallmark of cellular aging, and telomerase-activating compounds are actively studied as potential anti-aging tools. Epithalon’s telomere data, while primarily from the Khavinson group, represents the most directly targeted approach to this aging mechanism in the research peptide field.
Growth Hormone and IGF-1 Axis
The age-related decline in GH and IGF-1 — sometimes called somatopause — is associated with increased body fat, reduced lean mass, decreased bone density, and reduced physical function. Research with GHRH analogues (Tesamorelin, Sermorelin) and GHRPs (Ipamorelin) has shown that partially restoring GH axis activity can reverse some of these changes in animal and human studies. The balance between desired anabolic effects and potential IGF-1-mediated cancer risk remains an active research question in GH axis anti-aging research.
Mitochondrial Peptides
MOTS-c, Humanin, and SS-31 address the mitochondrial dysfunction hallmark of aging. MOTS-c’s age-related decline and exercise-mimetic effects in aged animal models, Humanin’s age-related decline and elevated levels in centenarians, and SS-31’s restoration of mitochondrial function in aging models all position these compounds in the most mechanistically specific anti-aging research area currently active in the peptide field.
NAD+ and Metabolic Aging
5-Amino-1MQ represents a peptide-adjacent approach to NAD+ restoration through NNMT inhibition. NAD+ decline with age is well-documented and linked to sirtuin deactivation, impaired DNA repair, and mitochondrial dysfunction. Compounds that elevate NAD+ through various mechanisms are among the most actively researched anti-aging interventions.
Bioregulator Peptides
Khavinson’s bioregulator program has produced animal longevity data for multiple compounds including Epithalon, Thymalin, and Epithalamin. Animal studies showing 20 to 30% lifespan extension in some models with peptide bioregulators represent significant findings that await broader independent replication.
Conclusion
Anti-aging peptide research is mechanistically diverse, spanning telomere biology, GH axis restoration, mitochondrial function, and epigenetic regulation. The most credible current evidence involves compounds with well-characterized mechanisms targeting established aging hallmarks. This field continues to evolve rapidly as understanding of aging biology deepens.
Source These Compounds at FenaLife
FenaLife supplies research-grade NAD+ 500mg and MOTS-c 10mg, each with Janoshik third-party COA. Browse the longevity research catalog →
For research use only. Not for human consumption.